Lemelson Center, National Museum of American History Search this
Type:
YouTube Videos
Uploaded:
2021-06-22T19:19:02.000Z
Views:
131
Video Title:
Vaccines, Intellectual Property, and Global Equity
Description:
The roll out of effective COVID-19 vaccines is happening at a historically unprecedented pace. Manufacturing and delivering vaccines to some 7.8 billion people worldwide, however, has reignited tensions about the role of intellectual property in medicine. How risky is vaccine development? What is protected by vaccine patents? What role do US and EU patents play for international vaccine distribution? The Smithsonian’s Lemelson Center for the Study of Invention and Innovation, in collaboration with George Mason University’s Center for the Protection of Intellectual Property, presents this exploration of the legal and policy debate regarding patents on vaccines. The program, recorded live on Thursday, June 10, 2021, begins with a brief overview of vaccine history and a virtual tour of relevant objects from the Smithsonian’s collections and is followed by a panel discussion concerning the ethical, commercial, and global health implications of vaccine patents. Opening Historical Perspective: Arthur Daemmrich – Director, Lemelson Center for the Study of Invention and Innovation, Smithsonian’s National Museum of American History Panelists: Dan Laster – Director, Washington State COVID-19 Vaccine Action Command and Coordination System (VACCS) Center Arti K. Rai – Elvin R. Latty Professor of Law and co-Director, Duke Law Center for Innovation Policy Eric Aaronson – Senior Vice President and Chief Counsel, Intellectual Property, Pfizer Inc. Moderated by: Sean O’Connor, Executive Director & Senior Scholar, Center for the Protection of Intellectual Property, Antonin Scalia Law School, George Mason University
